Coronary artery revascularization evaluation--a multicenter registry with seven years of follow-up.

16 Although early results of the SYNTAX trial demonstrated no difference in mortality, 17 the most recent 5‐year follow‐up reports a highly significant difference in all‐cause death (9.2% versus 14.6%; P =0.006) as well as cardiac death (4.0% versus 9.2%; P <0.001), favoring CABG versus PCI in for patients with triple‐vessel disease.

also in 132,142 other papers